Current status: 839 hESC lines, 3268 hiPSC lines, and 100 clinical studies, and 438 certificates
Monthly statistic from Sep 1, 2022
Posted on September 1, 2022
| total lines | 4107 |
| hESC lines | 839 |
| hiPSC lines | 3268 |
| derivation countries | 43 |
| projects | 245 |
| providers | 750 |
| clinical studies | 100 |
| subclones | 1704 |
| certificates | 438 |
| cell line certificates | 312 |
| project certificates | 126 |